Literature DB >> 18222668

Effects of carvacrol on defects of ischemia-reperfusion in the rat liver.

Mediha Canbek1, Mustafa Uyanoglu, Gokhan Bayramoglu, Hakan Senturk, Nilufer Erkasap, Tulay Koken, Sema Uslu, Canan Demirustu, Erinc Aral, K Husnu Can Baser.   

Abstract

Many plants found in nature have been used to treat various illnesses. One such plant is oregano (Kekik in Turkish). Health beneficial effects of carvacrol obtained from oregano oil have been shown scientifically. We have investigated the comparative effects of carvacrol in the liver of rats subjected to ischemia-reperfusion defect, with silymarin. To test the effects we formed four groups using male Wistar albino rats. Group I was control. The other three groups of animals were administered 60min prior to surgical operation single doses of physiological serum, carvacrol and silymarin, respectively. Group II, III and IV animal were subjected to 45min long liver ischemia and 60min reperfusion. Blood and tissue samples were collected for biochemical and histological analysis following the test. AST and ALT values obtained after biochemical analysis of the serums showed statistically significant difference in group II than the other three groups. A statistical evaluation of the serum AST levels among the groups II, III and IV showed that both groups III and IV which had no difference in between were significantly different in a positive way from group II (p<0.001). As to the serum ALT levels, difference between group II and group III (p<0.001) and group II and group IV (p<0.01) was found significant. No statistical difference was observed in groups I, III and IV for GSH, MDA and CAT levels of the liver. A statistical evaluation of the GSH level in group III and group IV was found to be significantly different from group II (p<0.001) without any difference between them. A similar evaluation for MDA and CAT levels among the revealed no difference between group III and group IV, however, group II showed difference with group II and group IV (p<0.05). Histological findings were in harmony with the biochemical results. We conclude that carvacrol protects the liver against defects caused by ischemia and reperfusion, and carvacrol is not hepatotoxic at the applied dosage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222668     DOI: 10.1016/j.phymed.2007.11.022

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  16 in total

1.  Effects of long-term silymarin oral supplementation on the blood biochemical profile of rainbow trout (Oncorhynchus mykiss).

Authors:  Mahdi Banaee; Antoni Sureda; Ali Reza Mirvaghefi; Golam Reza Rafei
Journal:  Fish Physiol Biochem       Date:  2011-04-26       Impact factor: 2.794

2.  Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents.

Authors:  Irisdalva S Oliveira; Francilene V da Silva; Ana Flávia S C Viana; Márcio R V dos Santos; Lucindo J Quintans-Júnior; Maria do Carmo C Martins; Paulo H M Nunes; Francisco de A Oliveira; Rita de C M Oliveira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-28       Impact factor: 3.000

3.  Protective effects of carvacrol against methotrexate-induced testicular toxicity in rats.

Authors:  Mansur Daggulli; Onur Dede; Mehmet Mazhar Utangac; Mehmet Nuri Bodakci; Namık Kemal Hatipoglu; Necmettin Penbegul; Ahmet Ali Sancaktutar; Yaşar Bozkurt; Gül Türkçü; Hatice Yüksel
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in rats.

Authors:  Gül Türkcü; Ulaş Alabalık; Ayşe Nur Keleş; Mehtap Bozkurt; İbrahim İbiloğlu; Uğur Fırat; Hüseyin Büyükbayram
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats.

Authors:  Subramaniyan Jayakumar; Arumugam Madankumar; Selvamani Asokkumar; Subramanian Raghunandhakumar; Krishnan Gokula dhas; Sattu Kamaraj; Michael Georget Josephine Divya; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2011-08-31       Impact factor: 3.396

6.  Carvacrol protects neuroblastoma SH-SY5Y cells against Fe(2+)-induced apoptosis by suppressing activation of MAPK/JNK-NF-κB signaling pathway.

Authors:  Zhen-wen Cui; Zheng-xing Xie; Bao-feng Wang; Zhi-hong Zhong; Xiao-yan Chen; Yu-hao Sun; Qing-fang Sun; Guo-yuan Yang; Liu-guan Bian
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

7.  Carvacrol attenuates diabetes-associated cognitive deficits in rats.

Authors:  Wenjing Deng; Hong Lu; Junfang Teng
Journal:  J Mol Neurosci       Date:  2013-07-23       Impact factor: 3.444

8.  Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia/reperfusion injury in mice.

Authors:  Hailong Yu; Zeng-Li Zhang; Jing Chen; Aijie Pei; Fang Hua; Xuanchen Qian; Jinjiang He; Chun-Feng Liu; Xingshun Xu
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

9.  Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats.

Authors:  Gokhan Bayramoglu; Hakan Senturk; Aysegul Bayramoglu; Mustafa Uyanoglu; Suat Colak; Ayse Ozmen; Durdane Kolankaya
Journal:  Cytotechnology       Date:  2013-04-12       Impact factor: 2.058

10.  Carvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats.

Authors:  Lida Suo; Kai Kang; Xun Wang; Yonggang Cao; Haifeng Zhao; Xueying Sun; Liquan Tong; Feng Zhang
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.